STOCK TITAN

Conformis Inc. - CFMS STOCK NEWS

Welcome to our dedicated news page for Conformis (Ticker: CFMS), a resource for investors and traders seeking the latest updates and insights on Conformis.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Conformis's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Conformis's position in the market.

Rhea-AI Summary
restor3d completes acquisition of Conformis, creating a leading producer of personalized orthopedic devices with additive manufacturing capabilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
acquisition
-
Rhea-AI Summary
Conformis, Inc. announced financial results for Q2 2023, with total revenue of $13.0 million, a decrease of 15% YoY. Product revenue was $12.5 million, a decrease of 17% YoY. Conformis hip system revenue increased by 30% YoY. The company has cash and cash equivalents of $26.2 million as of June 30, 2023. Conformis also announced a merger agreement to be acquired by restor3d in a cash acquisition.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
Rhea-AI Summary
restor3d, Inc. and Conformis, Inc. have entered into a definitive merger agreement, with restor3d acquiring all outstanding shares of common stock of Conformis at $2.27 per share in cash, representing a 96 percent premium to the closing price of Conformis stock on June 22, 2023. The merger will create a leading personalized 3D-printed orthopedic medical device company. The companies plan to leverage their respective strengths in artificial-intelligence-driven implant design, digital automation, and 3D printed osseointegrative biomaterials to offer clinically differentiated and cost-effective solutions across the orthopedic landscape.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
87.07%
Tags
acquisition
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.05%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.05%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.72%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.94%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.21%
Tags
none
Conformis Inc.

Nasdaq:CFMS

CFMS Rankings

CFMS Stock Data

17.88M
6.93M
6.29%
22.56%
1.06%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Billerica

About CFMS

our mission patients vary in more ways than gender, race, and size. at conformis, we believe that optimizing implant fit and performance requires a patient-specific approach. our mission is to provide best-in-class, patient-specific implants and instrumentation that offer unique advantages over traditional orthopedic implants. we start with a simple idea: make the implant fit the patient rather than forcing the patient to fit the implant. our implants are individually sized and shaped to fit to each patient’s unique anatomy, providing precise anatomic fit and preserving healthy tissue. our disposable, patient-specific cutting and placement guides also eliminate many of the tools required for traditional orthopedic surgery and simplify surgical technique. by combining our personalized implants with our unique instrumentation, a surgeon is able to provide a custom solution that preserves more of a patient’s joint and minimizes surgical trauma. our company conformis, inc. is a privately h